These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 35021044)

  • 1. Vascular endotheliitis associated with infections: Its pathogenetic role and therapeutic implication.
    Hattori Y; Hattori K; Machida T; Matsuda N
    Biochem Pharmacol; 2022 Mar; 197():114909. PubMed ID: 35021044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications.
    Ma Z; Yang KY; Huang Y; Lui KO
    J Mol Cell Cardiol; 2022 Mar; 164():69-82. PubMed ID: 34838588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID-19-Mechanisms and Therapeutic Targets.
    Fodor A; Tiperciuc B; Login C; Orasan OH; Lazar AL; Buchman C; Hanghicel P; Sitar-Taut A; Suharoschi R; Vulturar R; Cozma A
    Oxid Med Cell Longev; 2021; 2021():8671713. PubMed ID: 34457119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autopsy-Based Pulmonary and Vascular Pathology: Pulmonary Endotheliitis and Multi-Organ Involvement in COVID-19 Associated Deaths.
    Haberecker M; Schwarz EI; Steiger P; Frontzek K; Scholkmann F; Zeng X; Höller S; Moch H; Varga Z
    Respiration; 2022; 101(2):155-165. PubMed ID: 34525475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses.
    Nascimento Conde J; Schutt WR; Gorbunova EE; Mackow ER
    mBio; 2020 Dec; 11(6):. PubMed ID: 33310781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Role of Platelet-Endothelium Interactions in the Pathogenesis of Severe SARS-CoV-2 Infection-Associated Myocardial Injury.
    Rossouw TM; Anderson R; Manga P; Feldman C
    Front Immunol; 2022; 13():776861. PubMed ID: 35185878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial dysfunction in COVID-19: Current findings and therapeutic implications.
    Nägele MP; Haubner B; Tanner FC; Ruschitzka F; Flammer AJ
    Atherosclerosis; 2020 Dec; 314():58-62. PubMed ID: 33161318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-COVID-19 Syndrome (PC19S): Chronic Reactive Endotheliitis and Disseminated Vascular Disease.
    López Castro J
    Acta Med Port; 2020 Dec; 33(12):859. PubMed ID: 33496258
    [No Abstract]   [Full Text] [Related]  

  • 9. Vascular Endothelial Glycocalyx Damage in COVID-19.
    Yamaoka-Tojo M
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33352699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin.
    Qian Y; Lei T; Patel PS; Lee CH; Monaghan-Nichols P; Xin HB; Qiu J; Fu M
    J Virol; 2021 Nov; 95(23):e0139621. PubMed ID: 34549987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of synthetic glucocorticoids in COVID-19 endothelites.
    Ferrara F; Vitiello A
    Naunyn Schmiedebergs Arch Pharmacol; 2021 May; 394(5):1003-1007. PubMed ID: 33443616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of sepsis on endothelium and clinical implications.
    Dolmatova EV; Wang K; Mandavilli R; Griendling KK
    Cardiovasc Res; 2021 Jan; 117(1):60-73. PubMed ID: 32215570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins and PCSK9 inhibitors: What is their role in coronavirus disease 2019?
    Barkas F; Milionis H; Anastasiou G; Liberopoulos E
    Med Hypotheses; 2021 Jan; 146():110452. PubMed ID: 33333472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial dysfunction contributes to COVID-19-associated vascular inflammation and coagulopathy.
    Zhang J; Tecson KM; McCullough PA
    Rev Cardiovasc Med; 2020 Sep; 21(3):315-319. PubMed ID: 33070537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endotheliitis in COVID-19].
    Varga Z
    Pathologe; 2020 Dec; 41(Suppl 2):99-102. PubMed ID: 33306138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 Vasculitis and vasculopathy-Distinct immunopathology emerging from the close juxtaposition of Type II Pneumocytes and Pulmonary Endothelial Cells.
    Giryes S; Bragazzi NL; Bridgewood C; De Marco G; McGonagle D
    Semin Immunopathol; 2022 May; 44(3):375-390. PubMed ID: 35412072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of Pulmonary Vasculopathy in Acute and Long-Term COVID-19: A Review.
    Riou M; Coste F; Meyer A; Enache I; Talha S; Charloux A; Reboul C; Geny B
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial injury exacerbates coronavirus disease 2019: The role of endothelial glycocalyx protection.
    Okada H; Yoshida S; Hara A; Ogura S; Tomita H
    Microcirculation; 2021 Apr; 28(3):e12654. PubMed ID: 32791568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies.
    Xu SW; Ilyas I; Weng JP
    Acta Pharmacol Sin; 2023 Apr; 44(4):695-709. PubMed ID: 36253560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.